Fact CheckerSign in

NCT07514130Active, not recruitingEarly phase 1

Assessment of Volume Status in Preeclampsia Post- SpinalAnasthesia:Utilizing Ultrasound " Evaluation of Lung and Inferior Vena Cava"

Assessment of Volume Status in Preeclampsia Post- SpinalAnasthesia:Utilizing Ultrasound " Evaluation of Lung and Inferior Vena Cava"AComparative Study

Source: ClinicalTrials.gov · Last updated 7 Apr 2026

Brief summary (registry, in English)

Primary aim Assess the accuracy and reliability of ultrasound evaluation of lung and inferior vena cava in determining volume status post-spinal anesthesia in pre-eclampsia patients. Measure the correlation between ultrasound findings and the traditional methods. Determine if ultrasound evaluation can predict fluid responsiveness and guide fluid management in this population. Secondary aim The secondary outcomes are: Investigate the association between volume status as determined by ultrasound and clinical outcomes such as maternal morbidity, neonatal outcomes, and length of hospital stay. Explore the feasibility and practicality of incorporating ultrasound evaluation into routine clinical practice for volume assessment in pre-eclampsiapatients post-spinal anesthesia. Consider patient satisfaction and acceptance of ultrasound evaluation compared to traditional methods.

Status (registry)
Active, not recruiting
Phase (registry)
Early phase 1
Study type
Interventional
Enrollment
62 (actual)
First submitted
24 Mar 2026
Start date
1 Aug 2024
Primary completion date
20 Jul 2025
Lead sponsor
Menoufia University
NCT number
NCT07514130

What you commit to

  • Study type: Interventional · Early phase 1
  • Participants enrolled: 62
  • From 1 Aug 2024 to the primary completion date, 20 Jul 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patient with other co morbidity sever cardiovascular or central nervous disease.

Age

  • Age \<19 or \>40 years, gestational age \<36 weeks, body mass index (BMI)≥40kg/m2.

Other

  • Women presenting in emergency delivery.

Who the study is looking for

  • Age 20 to35 years
  • Gestational age 36 weeks
  • Body mass index (BMI) \<35kg/m2.
  • Mild preeclampsia

Age in the registry: 20 years to 35 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Menofia University
Coordinator of this site? Confirm its status
Shibīn al KawmEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.